A Three-Dimensional Sensor to Recognize Amyloid‑β in Blood Plasma of Patients

A Three-Dimensional Sensor to Recognize Amyloid‑β in Blood Plasma of Patients

Bibliographic Details
Main Authors:	Jukwan Na, Euimin Hwang, Jun Shik Choi, Min-Jin Ji, Young Noh, Yong-beom Lim, Heon-Jin Choi
Format:	Article
Language:	English
Published:	American Chemical Society 2020-10-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.0c03578

Similar Items

Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β
by: Elisabet Wahlberg, et al.
Published: (2017-07-01)

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
by: Min Young Chun, et al.
Published: (2023-03-01)

Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline
by: Gyihyaon Yun, et al.
Published: (2021-10-01)

Cold Atmospheric Plasma Modification of Amyloid β
by: Maho Yagi-Utsumi, et al.
Published: (2021-03-01)

Association of plasma amyloid-β oligomerization with theta/beta ratio in older adults
by: Heewon Bae, et al.
Published: (2023-12-01)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
by: Min Jeong Wang, et al.
Published: (2017-12-01)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
by: Young Chul Youn, et al.
Published: (2019-05-01)

Tailoring Hydrophobic Interactions between Probes and Amyloid‑β Peptides for Fluorescent Monitoring of Amyloid‑β Aggregation
by: Sonam Kim, et al.
Published: (2018-05-01)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
by: Noelia Fandos, et al.
Published: (2017-01-01)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
by: Rosha Babapour Mofrad, et al.
Published: (2021-07-01)

Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease
by: Yuan Cheng, et al.
Published: (2022-05-01)

Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy
by: Kazuto Yamashita, et al.
Published: (2022-06-01)

Amyloid β levels in human red blood cells.
by: Takehiro Kiko, et al.
Published: (2012-01-01)

Cerebral amyloid angiopathy related inflammation: An under recognized but treatable complication of cerebral amyloid angiopathy
by: Alexander Berry-Noronha, MBBS, et al.
Published: (2023-07-01)

Immunoprecipitation of amyloid fibrils by the use of an antibody that recognizes a generic epitope common to amyloid fibrils.
by: Erin R Greiner, et al.
Published: (2014-01-01)

Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
by: Jung-Min Pyun, et al.
Published: (2024-02-01)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
by: Seong Soo A. An, et al.
Published: (2017-10-01)

Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer’s Disease
by: Mélissa Gentreau, et al.
Published: (2022-06-01)

Intracellular cleavage of amyloid β by a viral protease NIa prevents amyloid β-mediated cytotoxicity.
by: Baehyun Shin, et al.
Published: (2014-01-01)

Oligomerization by co-assembly of β-amyloid and α-synuclein
by: Jin Ryoun Kim
Published: (2023-03-01)

Prediction of Amyloid β-Positivity with both MRI Parameters and Cognitive Function Using Machine Learning
by: Hye Jin Park, et al.
Published: (2023-05-01)

Recognizing Banknote Fitness with a Visible Light One Dimensional Line Image Sensor
by: Tuyen Danh Pham, et al.
Published: (2015-08-01)

BODIPY Dyes as Probes and Sensors to Study Amyloid-β-Related Processes
by: Sergei V. Dzyuba
Published: (2020-11-01)

Permeability and Residual Plasma Volume of Human, Dutch Variant, and Rat Amyloid β-Protein 1-40 at the Blood–Brain Barrier
by: Joseph F. Poduslo, et al.
Published: (1997-01-01)

Antibodies Raised Against an Aβ Oligomer Mimic Recognize Pathological Features in Alzheimer’s Disease and Associated Amyloid-Disease Brain Tissue
by: Adam G. Kreutzer, et al.
Published: (2023-12-01)

Amyloid‐β sequester proteins as blood‐based biomarkers of cognitive decline
by: Kazuhiko Uchida, et al.
Published: (2015-06-01)

Perceiving and recognizing three-dimensional forms
by: Sinha, Pawan
Published: (2005)

The global Alzheimer's Association round robin study on plasma amyloid β methods
by: Josef Pannee, et al.
Published: (2021-01-01)

Plasma level of Amyloid β42 Is independent of neuronal function in Alzheimer's Disease
by: Dimitriadis Athanasios S, et al.
Published: (2008-04-01)

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
by: Julie K. Wisch, et al.
Published: (2023-01-01)

Accurate Transmission-Less Attenuation Correction Method for Amyloid-β Brain PET Using Deep Neural Network
by: Bo-Hye Choi, et al.
Published: (2021-07-01)

Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
by: Hyuk Sung Kwon, et al.
Published: (2023-10-01)

β2‐microglobulin: An essential coaggregation factor with β‐amyloid in amyloid pathology
by: Chongyun Wu, et al.
Published: (2023-12-01)

Independent effect of body mass index variation on amyloid-β positivity
by: Sung Hoon Kang, et al.
Published: (2022-07-01)

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status
by: Keun You Kim, et al.
Published: (2022-11-01)

Multifunctionalized Reduced Graphene Oxide Biosensors for Simultaneous Monitoring of Structural Changes in Amyloid-β 40
by: Dahye Jeong, et al.
Published: (2018-05-01)

The relationship between blood lipids and plasma amyloid beta is depend on blood pressure: a population-based cross-sectional study
by: Ningwei Hu, et al.
Published: (2020-01-01)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
by: Jung-Min Pyun, et al.
Published: (2023-01-01)

Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study
by: Nunzio Pomara, et al.
Published: (2022-07-01)

Diagnostic performance of automated plasma amyloid-β assays combined with pre-analytical immunoprecipitation
by: Hans-W. Klafki, et al.
Published: (2022-09-01)